James Weisz, MD
Ophthalmology · New Haven, CTNPI 1639144967
Payments from drug & device makers
Across 203 payments — averaging $70.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$7K
- Eyepoint US, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Coherus Oncology, Inc.$937
- Genentech USA, Inc.$718
- Mallinckrodt Hospital Products Inc.$383
- plus $2K from 14 others
Across 2 payments — averaging $6856.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eyepoint US, Inc.$14K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 12 | $6,819 |
| Eyepoint US, Inc. | 20 | $2,058 |
| Regeneron Healthcare Solutions, Inc. | 44 | $1,272 |
| Coherus Oncology, Inc. | 10 | $937 |
| Genentech USA, Inc. | 32 | $718 |
| Mallinckrodt Hospital Products Inc. | 13 | $383 |
| Alimera Sciences, Inc. | 18 | $329 |
| Lumenis BE Inc | 1 | $321 |
| Apellis Pharmaceuticals, Inc. | 8 | $308 |
| AbbVie | 11 | $264 |
| Sandoz | 7 | $226 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $219 |
| Novartis | 5 | $190 |
| Astellas Pharma US Inc | 3 | $84 |
| Harrow Eye, LLC | 2 | $59 |
| ANI Pharmaceuticals, Inc. | 2 | $56 |
| Bausch & Lomb Americas Inc. | 3 | $54 |
| Kala Pharmaceuticals, Inc. | 2 | $49 |
| Mallinckrodt Enterprises LLC | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
How this compares
$14,381 in reported general payments places this provider in the 90th percentile of 279 ophthalmology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in New Haven
- Amir CohenNew Haven$441K
- Anthony DanielsNew Haven$66K
- Paul KangNew Haven$40K
- Brian HaflerNew Haven$15K
- Kristen NwanyanwuNew Haven$12K
- Lucian del PrioreNew Haven$9K
- Gargi VoraNew Haven$7K
- James TsaiNew Haven$7K
- Wayne LarrisonNew Haven$5K
- Sara NetterNew Haven$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.